171 related articles for article (PubMed ID: 16039318)
1. Undue inducement in clinical research.
Martin R
Lancet; 2005 Jul 23-29; 366(9482):275-6. PubMed ID: 16039318
[No Abstract] [Full Text] [Related]
2. Undue inducement in clinical research in developing countries: is it a worry?
Emanuel EJ; Currie XE; Herman A;
Lancet; 2005 Jul 23-29; 366(9482):336-40. PubMed ID: 16039339
[No Abstract] [Full Text] [Related]
3. "Undue inducement' as coercive offers.
McGregor J
Am J Bioeth; 2005; 5(5):24-5. PubMed ID: 16179302
[No Abstract] [Full Text] [Related]
4. Undue inducement.
Glantz L; Grodin M
Lancet; 2005 Oct 15-21; 366(9494):1356-7. PubMed ID: 16226609
[No Abstract] [Full Text] [Related]
5. Undue inducement: nonsense on stilts?
Emanuel EJ
Am J Bioeth; 2005; 5(5):9-13; discussion W8-11, W17. PubMed ID: 16179296
[No Abstract] [Full Text] [Related]
6. Undue fear of inducements in research in developing countries.
Arnason G; Van Niekerk A
Camb Q Healthc Ethics; 2009 Apr; 18(2):122-9. PubMed ID: 19250565
[No Abstract] [Full Text] [Related]
7. For-profit clinical trials in developing countries--those troublesome patient benefits.
Schuklenk U
Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975
[No Abstract] [Full Text] [Related]
8. Money for research participation: does in jeopardize informed consent?
Grady C
Am J Bioeth; 2001; 1(2):40-4. PubMed ID: 11951886
[TBL] [Abstract][Full Text] [Related]
9. Is informed consent enough? Monetary incentives for research participation and the integrity of biomedicine.
Kuczewski M
Am J Bioeth; 2001; 1(2):49-51. PubMed ID: 11951891
[No Abstract] [Full Text] [Related]
10. Undue inducement: the only objection to payment?
VanderWalde A
Am J Bioeth; 2005; 5(5):25-7. PubMed ID: 16179303
[No Abstract] [Full Text] [Related]
11. Benefits to research subjects in international trials: do they reduce exploitation or increase undue inducement?
Ballantyne A
Dev World Bioeth; 2008 Dec; 8(3):178-91. PubMed ID: 19046255
[TBL] [Abstract][Full Text] [Related]
12. Payment for research participation: a coercive offer?
Wertheimer A; Miller FG
J Med Ethics; 2008 May; 34(5):389-92. PubMed ID: 18448723
[TBL] [Abstract][Full Text] [Related]
13. Ending concerns about undue inducement.
Emanuel EJ
J Law Med Ethics; 2004; 32(1):100-5. PubMed ID: 15152431
[No Abstract] [Full Text] [Related]
14. The perverse consequences of a proposed global tax on research.
MacDonald C; Walton N
Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
[No Abstract] [Full Text] [Related]
15. Guest editorial: vulnerability revisited.
Schroeder D; Arnason G
Camb Q Healthc Ethics; 2009 Apr; 18(2):110-1. PubMed ID: 19250563
[No Abstract] [Full Text] [Related]
16. Adolescents as doubly-vulnerable research subjects.
Kopelman LM
Am J Bioeth; 2004; 4(1):50-2. PubMed ID: 15035950
[No Abstract] [Full Text] [Related]
17. [Clinical trials in developing countries: who should define ethics?].
Béréterbide F; Hirsch F
Bull Soc Pathol Exot; 2008 Apr; 101(2):102-5. PubMed ID: 18543701
[TBL] [Abstract][Full Text] [Related]
18. A quartet of criticisms.
Vanderpool HY
Am J Bioeth; 2005; 5(5):16-9. PubMed ID: 16179299
[No Abstract] [Full Text] [Related]
19. Is there coercion or undue inducement to participate in health research in developing countries? An example from Rakai, Uganda.
Nalugoda F; Wagman J; Kiddugavu M; Kiwanuka N; Garrett E; Gray RH; Serwadda D; Wawer MJ; Emanuel EJ
J Clin Ethics; 2009; 20(2):141-9. PubMed ID: 19554819
[No Abstract] [Full Text] [Related]
20. Money, consent, and exploitation in research.
Ashcroft RE
Am J Bioeth; 2001; 1(2):62-3. PubMed ID: 11951898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
